Financials • Global Banking, Institutional Markets & Wealth Management • SIC 6211
$894.55 ▼ -33.18
(-3.58%)
MKT CAP: $260.83B • VOL: 2.14M
52W L $754 52W H $1,154
GS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-02-25 | FY 2024
FILED 2026-02-25 | FY 2023
FILED 2026-02-25 | FY 2022
FILED 2025-02-27 | FY 2021
FILED 2024-02-23 |
|---|---|---|---|---|---|
| Revenue (Total Sales) | $58.28B | $53.51B | $46.25B | $47.37B | $59.34B |
| YoY Revenue Growth % | +8.9% | +15.7% | -2.4% | -20.2% | +33.2% |
| Gross Profit | — | — | — | — | — |
| Gross Margin % | — | — | — | — | — |
| Research & Development (R&D) | — | — | — | — | — |
| Operating Income (EBIT) | $21.85B | $18.40B | $10.74B | $13.49B | $27.04B |
| Operating Margin % | 37.5% | 34.4% | 23.2% | 28.5% | 45.6% |
| Net Income (GAAP) | $17.18B | $14.28B | $8.52B | $11.26B | $21.64B |
| EBITDA (Normalized) | $24.03B | $20.79B | $15.60B | $15.94B | $29.06B |
| Diluted EPS ($/sh) | $51.32 | $40.54 | $22.87 | $30.06 | $59.45 |
| Operating Cash Flow (OCF) | -$45.15B | -$13.21B | -$12.59B | $8.71B | $6.30B |
| Capital Expenditures (CapEx) | $2.06B | $2.09B | $2.32B | $3.75B | $4.67B |
| Free Cash Flow (FCF) | -$47.22B | -$15.30B | -$14.90B | $4.96B | $1.63B |
| FCF Margin % | -81.0% | -28.6% | -32.2% | 10.5% | 2.8% |
| Return on Invested Capital (ROIC %) | 13.7% | 11.7% | 7.3% | 9.6% | 19.7% |
| Cash & Short-Term Equivalents | $164.26B | $182.09B | $241.58B | $241.82B | $261.04B |
| Total Debt (Short + Long Term) | $355.96B | $312.34B | $317.82B | $308.10B | $301.05B |
| Total Stockholders' Equity | $124.97B | $122.00B | $116.91B | $117.19B | $109.93B |
| LINE ITEM (USD / %) | Q2 2026
FILED 2026-08-03 | Q1 2026
FILED 2026-05-01 | Q4 2025
FILED 2026-02-25 | Q3 2025
FILED 2025-10-31 | Q2 2025
FILED 2026-08-03 | Q1 2025
FILED 2026-05-01 |
|---|---|---|---|---|---|---|
| Revenue (Total Sales) | $20.34B | $17.23B | $13.45B | $15.18B | $14.58B | $15.06B |
| YoY Revenue Growth % | +39.5% | +14.4% | -3.0% | +19.6% | +14.6% | +6.0% |
| Gross Profit | — | — | — | — | — | — |
| Gross Margin % | — | — | — | — | — | — |
| Research & Development (R&D) | — | — | — | — | — | — |
| Operating Income (EBIT) | $8.56B | $6.49B | $5.86B | $5.39B | $4.96B | $5.65B |
| Operating Margin % | 42.1% | 37.6% | 43.5% | 35.5% | 34.0% | 37.5% |
| Net Income (GAAP) | $6.63B | $5.63B | $4.62B | $4.10B | $3.72B | $4.74B |
| EBITDA (Normalized) | $9.07B | $6.98B | $6.44B | $5.92B | $5.58B | $6.15B |
| Diluted EPS ($/sh) | $20.98 | $17.55 | $14.04 | $12.25 | $10.91 | $14.12 |
| Operating Cash Flow (OCF) | $6.11B | -$31.87B | -$16.28B | $2.68B | $5.67B | -$37.23B |
| Capital Expenditures (CapEx) | $502.0M | $565.0M | $531.0M | $558.0M | $476.0M | $499.0M |
| Free Cash Flow (FCF) | $5.60B | -$32.43B | -$16.81B | $2.12B | $5.20B | -$37.73B |
| FCF Margin % | 27.6% | -188.3% | -124.9% | 14.0% | 35.6% | -250.5% |
| Return on Invested Capital (ROIC %) | 21.6% | 18.3% | 14.8% | 13.2% | 12.0% | 15.3% |
| Cash & Short-Term Equivalents | $187.27B | $179.53B | $164.26B | $169.58B | $152.97B | $167.41B |
| Total Debt (Short + Long Term) | $437.87B | $396.30B | $355.96B | $349.30B | $348.97B | $333.87B |
| Total Stockholders' Equity | $122.74B | $122.78B | $124.97B | $124.40B | $124.10B | $124.30B |